back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2020-03-16 15:48 Tx date 2018-05-15 |
$CORV
Correvio Pharma Corp. |
Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
14,500 | ||
| Filed 2019-03-20 Tx date 2019-03-15 |
$CORV
Correvio Pharma Corp. |
Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$523,000
+100,000 vol $5.23 each |
475,000 | |
| Filed 2019-03-20 Tx date 2018-05-15 |
$CORV
Correvio Pharma Corp. |
Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
375,000 | ||
| Filed 2018-03-27 Tx date 2018-03-23 |
$COM
Cardiome Pharma Corp. |
Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$311,250
+125,000 vol $2.49 each |
375,000 | |
| Filed 2017-08-23 Tx date 2017-08-23 |
$COM
Cardiome Pharma Corp. |
Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,950
+8,500 vol $2.70 each |
14,500 | |
| Filed 2017-03-27 Tx date 2017-03-22 |
$COM
Cardiome Pharma Corp. |
Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$501,250
+125,000 vol $4.01 each |
250,000 | |
| Filed 2016-08-15 Tx date 2016-08-12 |
$COM
Cardiome Pharma Corp. |
Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$24,900
+6,000 vol $4.15 each |
6,000 | |
| Filed 2016-06-24 Tx date 2016-06-21 |
$COM
Cardiome Pharma Corp. |
Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$461,250
+75,000 vol $6.15 each |
125,000 | |
| Filed 2015-08-12 Tx date 2015-06-22 |
$COM
Cardiome Pharma Corp. |
Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-12 Tx date 2015-06-22 |
$COM
Cardiome Pharma Corp. |
Dean, David Cameron Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 |